quinazolines has been researched along with Neuralgia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahuja, VT; Allen, J; Bronson, JJ; Brown, JM; Camac, DM; Dasgupta, B; Dzierba, CD; Ghosh, K; Gulianello, M; Hamman, BD; Hartz, RA; Honkhambe, S; Hunihan, L; Kiefer, SE; Kostich, WA; Kumar, CMV; Lewis, M; Lippy, JS; Macor, JE; Manepalli, RKVLP; Muckelbauer, JK; Nara, SJ; Patankar, V; Pokross, M; Rajamani, R; Sarvasiddhi, SK; Surti, N | 1 |
| Bogacka, J; Ciechanowska, A; Dobrogowski, J; Makuch, W; Mika, J; Pawlik, K; Popiolek-Barczyk, K; Przeklasa-Muszynska, A; Rojewska, E | 1 |
| Bogacka, J; Ciapała, K; Dobrogowski, J; Kwiatkowski, K; Mika, J; Pawlik, K; Przeklasa-Muszynska, A | 1 |
| Cameron, MG; Kersten, C | 1 |
| Chen, Y; Wu, P | 1 |
| Bellampalli, SS; Chefdeville, A; Chew, LA; Colecraft, HM; François-Moutal, L; Gokhale, V; Ha, T; Khanna, M; Khanna, R; Luo, S; Moutal, A; Park, KD; Patwardhan, AM; Perez-Miller, S; Serafini, MJ; Shuja, Z; Streicher, JM; Yang, X; Yu, J | 1 |
| Balboni, G; Gadotti, VM; Lee, JY; M'Dahoma, S; Nam, JH; Onnis, V; Park, B; Zamponi, GW; Zhang, FX | 1 |
| Cameron, MG; Kersten, C; Laird, B; Mjåland, S | 1 |
| Ma, F; Westlund, KN; Zhang, L | 1 |
| Bourgoin, S; Hamon, M; Kayser, V; Michot, B; Viguier, F | 1 |
1 trial(s) available for quinazolines and Neuralgia
| Article | Year |
|---|---|
Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain.
Topics: Adult; Aged; Analgesics, Non-Narcotic; Antibodies, Monoclonal; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gefitinib; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Pain Measurement; Panitumumab; Prospective Studies; Quinazolines; Recurrence; Young Adult | 2015 |
9 other study(ies) available for quinazolines and Neuralgia
| Article | Year |
|---|---|
Bicyclic Heterocyclic Replacement of an Aryl Amide Leading to Potent and Kinase-Selective Adaptor Protein 2-Associated Kinase 1 Inhibitors.
Topics: Amides; Animals; Neuralgia; Protein Kinase Inhibitors; Quinazolines; Quinolines; Structure-Activity Relationship | 2022 |
CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
Topics: Analgesics, Opioid; Animals; Cold Temperature; Cytokines; Disease Models, Animal; Drug Synergism; Ganglia, Spinal; Hyperalgesia; Male; Mice; Morphine; Neuralgia; Peripheral Nerve Injuries; Quinazolines; Rats, Wistar; Receptors, CCR4; Sciatic Nerve; Spinal Cord; Touch | 2020 |
CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain.
Topics: Animals; Behavior, Animal; Biomarkers; Buprenorphine; Disease Models, Animal; Drug Synergism; Injections, Spinal; Male; Mice; Models, Animal; Morphine; Neuralgia; Pain Management; Quinazolines; Receptors, CCR4; Time Factors; Treatment Outcome | 2020 |
Differential effects of epidermal growth factor receptor inhibitors in a single patient with neuropathic pain.
Topics: Afatinib; ErbB Receptors; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neuralgia; Protein Kinase Inhibitors; Quinazolines | 2021 |
Evodiamine ameliorates paclitaxel-induced neuropathic pain by inhibiting inflammation and maintaining mitochondrial anti-oxidant functions.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cytokines; Disease Models, Animal; Ganglia, Spinal; Humans; Inflammation Mediators; Male; Membrane Potential, Mitochondrial; Mitochondria; Neuralgia; Oxidative Stress; Paclitaxel; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phytotherapy; Quinazolines; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Cells, Cultured; Uncoupling Protein 2 | 2019 |
Targeting the CaVα-CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy.
Topics: Analgesics; Animals; Calcitonin Gene-Related Peptide; Calcium Channel Blockers; Calcium Channels; Calcium Channels, N-Type; CHO Cells; Computer Simulation; Cricetulus; Excitatory Postsynaptic Potentials; Ganglia, Spinal; Hyperalgesia; Male; Neuralgia; Primary Cell Culture; Quinazolines; Rats; Rats, Sprague-Dawley; Spinal Cord | 2019 |
Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain.
Topics: Action Potentials; Acute Pain; Analgesics; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Neuralgia; Nociception; Quinazolines | 2016 |
Trigeminal nerve injury ErbB3/ErbB2 promotes mechanical hypersensitivity.
Topics: Animals; Blotting, Western; Disease Models, Animal; Hyperalgesia; Lapatinib; Male; Neuralgia; Pain Threshold; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Inbred F344; Receptor, ErbB-2; Receptor, ErbB-3; Trigeminal Nerve Injuries; Vibrissae | 2012 |
Differential effects of calcitonin gene-related peptide receptor blockade by olcegepant on mechanical allodynia induced by ligation of the infraorbital nerve vs the sciatic nerve in the rat.
Topics: Activating Transcription Factor 3; Animals; Biomarkers; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Hyperalgesia; Interleukin-6; Locomotion; Male; Maxillary Nerve; Neuralgia; Pain Measurement; Piperazines; Piperidines; Proto-Oncogene Proteins c-fos; Quinazolines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Calcitonin Gene-Related Peptide; RNA, Messenger; Rotarod Performance Test; Sciatic Nerve; Serotonin 5-HT1 Receptor Agonists; Tryptamines | 2012 |